Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
2,349,841
-
Share change
-
+2,199,841
-
Total reported value
-
$1,798,000
-
Price per share
-
$0.76
-
Number of holders
-
17
-
Value change
-
+$1,684,000
-
Number of buys
-
16
Institutional Holders of SILEXION THERAPEUTICS CORP WT EXP 081529 - Stock (MACAW) as of Q2 2021
As of 30 Jun 2021,
SILEXION THERAPEUTICS CORP WT EXP 081529 - Stock (MACAW) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,349,841 shares.
The largest 10 holders included
Sage Rock Capital Management LP, Linden Advisors LP, Castle Creek Arbitrage, LLC, Saba Capital Management, L.P., SECURITY BENEFIT LIFE INSURANCE CO /KS/, UBS OCONNOR LLC, PICTON MAHONEY ASSET MANAGEMENT, GOLDMAN SACHS GROUP INC, Polar Asset Management Partners Inc., and TENOR CAPITAL MANAGEMENT Co., L.P..
This page lists
17
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.